China · Delayed Price · Currency is CNY Xiangxue Pharmaceutical Statistics
Total Valuation
SHE:300147 has a market cap or net worth of CNY 7.19 billion. The enterprise value is 8.87 billion.
| Market Cap | 7.19B |
| Enterprise Value | 8.87B |
Important Dates
The last earnings date was Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300147 has 661.28 million shares outstanding. The number of shares has increased by 0.63% in one year.
| Current Share Class | 661.28M |
| Shares Outstanding | 661.28M |
| Shares Change (YoY) | +0.63% |
| Shares Change (QoQ) | -1.45% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 3.18% |
| Float | 485.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.71 |
| PB Ratio | -85.56 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 52.87 |
| P/OCF Ratio | 46.09 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 52.96, with an EV/FCF ratio of 65.21.
| EV / Earnings | -6.27 |
| EV / Sales | 5.81 |
| EV / EBITDA | 52.96 |
| EV / EBIT | n/a |
| EV / FCF | 65.21 |
Financial Position
The company has a current ratio of 0.24
| Current Ratio | 0.24 |
| Quick Ratio | 0.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | 8.55 |
| Debt / FCF | 10.56 |
| Interest Coverage | -59.94 |
Financial Efficiency
Return on equity (ROE) is -217.95% and return on invested capital (ROIC) is -3.76%.
| Return on Equity (ROE) | -217.95% |
| Return on Assets (ROA) | -0.41% |
| Return on Invested Capital (ROIC) | -3.76% |
| Return on Capital Employed (ROCE) | -60.37% |
| Weighted Average Cost of Capital (WACC) | 6.03% |
| Revenue Per Employee | 552,027 |
| Profits Per Employee | -511,332 |
| Employee Count | 2,769 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 3.37 |
Taxes
In the past 12 months, SHE:300147 has paid 41.71 million in taxes.
| Income Tax | 41.71M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +47.63% in the last 52 weeks. The beta is 0.54, so SHE:300147's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | +47.63% |
| 50-Day Moving Average | 9.80 |
| 200-Day Moving Average | 9.68 |
| Relative Strength Index (RSI) | 60.55 |
| Average Volume (20 Days) | 19,098,701 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300147 had revenue of CNY 1.53 billion and -1.42 billion in losses. Loss per share was -2.16.
| Revenue | 1.53B |
| Gross Profit | 438.16M |
| Operating Income | -46.37M |
| Pretax Income | -1.35B |
| Net Income | -1.42B |
| EBITDA | 136.89M |
| EBIT | -46.37M |
| Loss Per Share | -2.16 |
Balance Sheet
The company has 144.74 million in cash and 1.44 billion in debt, with a net cash position of -1.29 billion or -1.95 per share.
| Cash & Cash Equivalents | 144.74M |
| Total Debt | 1.44B |
| Net Cash | -1.29B |
| Net Cash Per Share | -1.95 |
| Equity (Book Value) | -84.09M |
| Book Value Per Share | -0.72 |
| Working Capital | -5.01B |
Cash Flow
In the last 12 months, operating cash flow was 156.09 million and capital expenditures -19.99 million, giving a free cash flow of 136.09 million.
| Operating Cash Flow | 156.09M |
| Capital Expenditures | -19.99M |
| Depreciation & Amortization | 183.26M |
| Net Borrowing | -45.26M |
| Free Cash Flow | 136.09M |
| FCF Per Share | 0.21 |
Margins
Gross margin is 28.66%, with operating and profit margins of -3.03% and -92.63%.
| Gross Margin | 28.66% |
| Operating Margin | -3.03% |
| Pretax Margin | -88.14% |
| Profit Margin | -92.63% |
| EBITDA Margin | 8.96% |
| EBIT Margin | -3.03% |
| FCF Margin | 8.90% |
Dividends & Yields
SHE:300147 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.63% |
| Shareholder Yield | -0.63% |
| Earnings Yield | -19.68% |
| FCF Yield | 1.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 14, 2014. It was a forward split with a ratio of 1.3.
| Last Split Date | Jul 14, 2014 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |